Recent Updates
Recently added Catalysts
RIGL Positive Sentiment

Rigel to Present at the 2024 Cantor Global Healthcare Conference

Thursday, September 12, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Rigel Pharmaceuticals, Inc. announced that its president and CEO, Raul Rodriguez, will present a company overview at the 2024 Cantor Global Healthcare Conference. The presentation is scheduled for September 19 at 9:10 am ET in New York, NY. Individuals interested in the presentation can access it via Rigel's Investor Relations website. This engagement highlights Rigel's ongoing commitment to raising awareness about its focus on hematologic disorders and cancer therapies.
Price reaction · baseline $12.97 (2024-09-11 close) · hit after-hours · clean, no other RIGL news in the window
day 0 close
-0.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Rigel Pharmaceuticals is actively participating in a prominent healthcare conference.
  • The presentation indicates ongoing company engagement and visibility in the market.
  • Raul Rodriguez, the CEO, is presenting, suggesting strong company leadership.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+9%
120-day peak, hindsight
Typical move
12.1%
average across 2 past catalysts
Lead asset
Fostamatinib
Phase 2 · Acute Respiratory Distress Syndrome

Full Press Release Details

SOUTH SAN FRANCISCO, Calif., Sept. 12, 2024 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that Raul Rodriguez, the company's president and CEO, will present a company overview at the Cantor Global Healthcare Conference on Thursday, September 19, at 9:10 am ET in New York, NY.
To access the live webcast or archived recording, visit the Investor Relations section of the company's website at www.rigel.com. Please connect to Rigel's website prior to the start of the live webcast to allow for any software downloads.
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California. For more information on Rigel, the Company's marketed products and pipeline of potential products, visit www.rigel.com.
Contact for Investors & Media:
Rigel Pharmaceuticals, Inc.

Frequently Asked Questions

When will Rigel Pharmaceuticals present at the Cantor Conference?

Rigel Pharmaceuticals will present on September 19 at 9:10 am ET.

Where can I access the webcast of Rigel's presentation?

The webcast will be available on Rigel's Investor Relations webpage.

What does Rigel Pharmaceuticals focus on?

Rigel Pharmaceuticals focuses on hematologic disorders and cancer.

When was Rigel Pharmaceuticals founded?

Rigel Pharmaceuticals was founded in 1996.

Where is Rigel Pharmaceuticals located?

Rigel Pharmaceuticals is based in South San Francisco, California.

ShareAdd on Google
Tags: RIGL Viatris Investor Conferences Healthcare healthcare conference Raul Rodriguez biotechnology hematologic disorders
Last updated: Sep 12, 2024

Biotech snapshot

Cash runway
$95M liquidity · $0M/mo burn
Low dilution risk
Lead asset
FostamatinibPhase 2
Acute Respiratory Distress Syndrome →

Catalyst track record

+9%
best trade around RIGL's most recent catalyst

Peak hindsight return over a 120-day window, across 2 tracked FDA/PDUFA catalysts for RIGL.

See every catalyst's timing & PoA →